The Faculty of Pharmacy – University of Kufa held a symposium on (the newly approved drug Lenzagolex).
It aims to explain the new medicine discovered estrogen-related diseases using hormone-releasing hormone antagonists to counter gonadotropins.
It included an explanation of the drug, its pharmacological properties, and the effects that accompany its use.
It concluded that the effect of anti-hormonal agents to counteract the gonads and reduce the size of deep lesions is a potential alternative to surgery in women suffering from estrogen-related disorders.